018742540

CELLJUVANT STUDY CELL-BASED ADJUVANT TECHNOLOGY

---

August 4, 2022

Trademark Summary

The trademark application CELLJUVANT STUDY CELL-BASED ADJUVANT TECHNOLOGY was filed by Seqirus Inc., a U.S. corporation (the "Applicant"). Application under examination.

The application was filed in English (French was selected as the second language).

---

Goods And Services

• The mark was filed in class 42 with following description of goods:
  
  1. Conducting clinical trials for pharmaceutical preparations
  2. Conducting clinical trials for flu vaccines
  3. Providing information about the results of clinical trials for flu vaccines
  4. Providing medical and scientific research information in the field of flu vaccines and flu vaccine clinical trials
  5. Pharmaceutical research and development.
• The mark was filed in class 44 with Pharmaceutical and medical information.